Pre-made Atorolimumab benchmark antibody (Whole mAb, anti-RHD therapeutic antibody, Anti-CD240D/DIIIc/HDFNRH/RH/RH30/RHCED/RHDVA(TT)/RHDel/RHPII/RHXIII/Rh4/RhDCw/RhII/RhK562-II/RhPI Antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-INN-743

Anti-RHD therapeutic antibody (Pre-made Atorolimumab biosimilar, Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Atorolimumab is an immunosuppressive drug directed against the Rhesus factor.[1][2]

Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-INN-743-1mg 1mg 3090
GMP-Bios-INN-743-10mg 10mg Inquiry
GMP-Bios-INN-743-100mg 100mg Inquiry
GMP-Bios-INN-743-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:

For more than 100mg, click here for inquiry. >>


Description

Products Name (INN Index) Pre-Made Atorolimumab Biosimilar, Whole Mab, Anti-Rhd Antibody: Anti-CD240D/DIIIc/HDFNRH/RH/RH30/RHCED/RHDVA(TT)/RHDel/RHPII/RHXIII/Rh4/RhDCw/RhII/RhK562-II/RhPI therapeutic antibody
INN Name Atorolimumab
TargetRHD
FormatWhole mAb
Derivationhuman
Species Reactivityhuman
CH1 IsotypeIgG3 - kappa
VD LCIgG3 - kappa
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
Companies0
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech0